Pursuing a Potential New Schizophrenia Treatment

Share on facebook
Share on google
Share on twitter
Share on linkedin

It’s about time for some original, better drugs to treat schizophrenia symptoms, and Dr. Philip Corlett, One Mind / Janssen Rising Star Award winner, is working hard to fill that bill. Please check out his research page for details on Dr. Corlett’s quest to address delusions and anhedonia with the already-approved drug Retigabine. Now, you can watch a recording of his live broadcast on this page.

My thanks to James Rossi and Chiko Loko for their interesting questions during the broadcast.

Comments are now closed. Tune in next month for an exciting live panel on new frontiers in depression research.

If you’d like to support amazing research for improved patient outcomes like Dr. Corlett is doing, please consider a tax-deductible donation to One Mind.

Happy viewing!  -Brandon

Your donation helps One Mind launch promising early-career investigators and their innovative research through the Rising Star Awards. Make a donation today that will accelerate ground-breaking discoveries in brain illness.